Description
Microbix has recently increased its production capacity of Rubella product and reduced manufacturing costs by developing and implementing a new, automated bioreactor production platform for production of Rubella virus, its largest and faste…
Amendment chain · 5 entries
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header. For this agreement: $249,500 at start, $249,500 after amendment #5 (+$0).
- #02018-09-03$249,500
- #22019-02-08$249,500
- #32019-12-19$249,500
- #42021-03-07$249,500
- #52021-09-12$249,500
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2018-09-03(start date) | $249,500 | — | Microbix has recently increased its production capacity of Rubella product and reduced manufacturing costs by… |
| #2 amendment | 2019-02-08 | $249,500 | +$0 | Microbix has recently increased its production capacity of Rubella product and reduced manufacturing costs by… |
| #3 amendment | 2019-12-19 | $249,500 | +$0 | Microbix has recently increased its production capacity of Rubella product and reduced manufacturing costs by… |
| #4 amendment | 2021-03-07 | $249,500 | +$0 | Microbix has recently increased its production capacity of Rubella product and reduced manufacturing costs by… |
| #5 amendment | 2021-09-12 | $249,500 | +$0 | Microbix has recently increased its production capacity of Rubella product and reduced manufacturing costs by… |
Related records · 8
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 103676466)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 062-2022-2023-Q4-00324 | Federal Economic Development Agency for Southern Ontario | Agence fédérale de développement économique pour le Sud de l'Ontario · Business Scale-up and Productivity (BSUP) | $3,592,500 | FY2020 |
| 062-2023-2024-Q4-00084 | Federal Economic Development Agency for Southern Ontario | Agence fédérale de développement économique pour le Sud de l'Ontario · Business Scale-up and Productivity (BSUP) | $3,592,500 | FY2020 |
| GC-2019-Q2-00005 | Federal Economic Development Agency for Southern Ontario | Agence fédérale de développement économique pour le Sud de l'Ontario · Business Scale-Up | $2,752,500 | FY2020 |
Other recipients funded under "Industrial Research Assistance Program – Contributions to Firms" by National Research Council Canada | Conseil national de recherches Canada (most recent first)
| Ref | Recipient | Fiscal year | Current value | FY |
|---|---|---|---|---|
| 172-2025-2026-Q2-1034675 | Mediphage Bioceuticals, Inc. | FY2027 | $63,380 | FY2027 |
| 172-2025-2026-Q3-1037522 | OBKIO INC. | FY2026 | $50,000 | FY2026 |
| 172-2025-2026-Q3-1037889 | SERVICES DE DEVELOPPEMENT PROFESSIONELS SDP INC | FY2026 | $25,000 | FY2026 |
| 172-2025-2026-Q2-1034040 | Griffith Foods Limited | FY2026 | $54,880 | FY2026 |
| 172-2025-2026-Q3-1037273 | Apollo Machine & Welding Ltd. | FY2026 | $230,000 | FY2026 |
Cite as: Glassbox record view · Federal grants & contributions · 172-2018-2019-Q3-914177 · retrieved 2026-11-15.